Revlimid and Oesophageal spasm - a phase IV clinical study of FDA data

Summary:

Oesophageal spasm is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Bactrim, and have Depression.

The phase IV clinical study analyzes which people have Oesophageal spasm when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Oesophageal spasm?

Oesophageal spasm (contraction of oesophagus) is found to be associated with 388 drugs and 474 conditions by eHealthMe. Check the latest studies of Oesophageal spasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

377,717 people reported to have side effects when taking Revlimid.
Among them, 11 people (0.0%) have Oesophageal spasm.

Among these 11 people:

How long have people been on Revlimid when they have Oesophageal spasm? *

What is the gender of people who have Oesophageal spasm when taking Revlimid? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Oesophageal spasm when taking Revlimid? *

What are other drugs people take besides Revlimid? *

What are other side effects people have besides Oesophageal spasm? *

Fainting (loss of consciousness and postural tone): 2 people, 18.18%
Gastric Ulcer (stomach ulcer): 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Vein Disorder: 1 person, 9.09%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 9.09%
Blindness: 1 person, 9.09%
Constipation: 1 person, 9.09%
Hoarseness Or Changing Voice: 1 person, 9.09%
Indigestion: 1 person, 9.09%
Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx): 1 person, 9.09%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 9.09%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
Depression: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Oesophageal spasm?

- Check whether Oesophageal spasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revlimid:

Revlimid (378,026 reports)

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophageal spasm:

Oesophageal spasm (388 drugs)

Browse all the conditions that are associated with Oesophageal spasm:

Oesophageal spasm (474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.